Literature DB >> 1862159

Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults.

N Breslau1, G C Davis, P Andreski.   

Abstract

To determine the prevalence of migraine and the risks for psychiatric disorders and suicide attempts associated with it, we studied a random sample of 1,007 young adults from a large Health Maintenance Organization in the Detroit, MI area. The lifetime prevalence of migraine was 7% in males and 16.3% in females. The rate of migraine was higher in persons with lower education and was equal in whites and blacks. Persons with migraine were at increased risk for affective and anxiety disorders, nicotine dependence, and alcohol or illicit drug abuse or dependence. There was a consistent trend toward higher psychiatric comorbidity in migraine with aura than in migraine without aura. Coexisting anxiety, which generally preceded migraine, was associated with a marked increase in the odds of major depression. Persons with migraine had higher rates of suicide attempts than persons without migraine. The odds ratio for suicide attempts, adjusted for coexisting major depression and other psychiatric and substance use disorders, in migraine with aura was 3.0 (95% confidence interval, 1.4-6.6). The coexistence of migraine with major depression, anxiety disorders, and suicide attempts has important clinical and research implications.

Entities:  

Mesh:

Year:  1991        PMID: 1862159     DOI: 10.1016/0165-1781(91)90102-u

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  83 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  The Zurich Study: XV. Suicide attempts in a cohort from age 20 to 30.

Authors:  J Angst; M Degonda; C Ernst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

3.  The anterior insula shows heightened interictal intrinsic connectivity in migraine without aura.

Authors:  Amy R Tso; Andrew Trujillo; Christine C Guo; Peter J Goadsby; William W Seeley
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

4.  Current research on chronic pain and suicide.

Authors:  D A Fishbain
Journal:  Am J Public Health       Date:  1996-09       Impact factor: 9.308

Review 5.  Burden of migraine. A review of its socioeconomic impact.

Authors:  G D Solomon; K L Price
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

6.  The Zurich Study: XXIII. Epidemiology of headache syndromes in the Zurich cohort study of young adults.

Authors:  K R Merikangas; A E Whitaker; H Isler; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 7.  Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon.

Authors:  Donald R Nixdorf; Ana M Velly; Aurelio A Alonso
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2008-05       Impact factor: 2.802

8.  Psychiatric comorbidity and suicide risk in patients with chronic migraine.

Authors:  Maurizio Pompili; Gianluca Serafini; Daniela Di Cosimo; Giovanni Dominici; Marco Innamorati; David Lester; Alberto Forte; Nicoletta Girardi; Sergio De Filippis; Roberto Tatarelli; Paolo Martelletti
Journal:  Neuropsychiatr Dis Treat       Date:  2010-04-07       Impact factor: 2.570

9.  The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.

Authors:  Hyun-Jung Park; Soon-Tae Lee; Ji-Young Shim; Bomie Kim; Sun-Hee Hwang; Sook-Hee Kim; Jeong-Eun Park; Jong-Ha Park; Se-Hee Jung; Jin-Young Ahn; Kon Chu; Manho Kim
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

10.  Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study.

Authors:  Han Le; Peer Tfelt-Hansen; Axel Skytthe; Kirsten Ohm Kyvik; Jes Olesen
Journal:  J Headache Pain       Date:  2011-03-10       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.